The (ADAPT) study evaluating MiniMed 780G advanced hybrid closed loop system vs SoC (multiple daily injections of insulin + intermittently scanned CGM) in adults aged ≥18yrs. with T1D
The results showed an improvement in clinical outcomes with the MiniMed 780G system; mean HbA1c (8.9% for MDI+isCGM @6mos. vs 7.5% @12mos. switched to AHCL), mean time in range (43.6 % vs 70.7%) while mean HbA1c for AHCL (7.3 % in AHCL @6mos. & 7.4 % remained on AHCL @12mos.)
The results from 2nd randomized controlled study (CLVer) sponsored by JDRF showed early intensive management, incl. the use of an automated insulin delivery system resulted in a superior time in the range of 78% vs 64% in the SoC @1yr. The results were presented at the ATTD conference & published in JAMA
Ref: PRNewswire | Image: Medtronic
Related News:- Medtronic Reports the First Patient Enrollment of Hugo Robotic-Assisted Surgery System
